This inventor holds 1 USPTO granted patent. Top assignee: Jiangsu Ocean University. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Qifa Wang: Innovator in Pharmaceutical Synthesis
Introduction
Qifa Wang is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceutical synthesis, particularly through his innovative methods for preparing complex chemical compounds. His work is characterized by efficiency and cost-effectiveness, making it suitable for industrial applications.
Latest Patents
Qifa Wang holds a patent for a method titled "Method for preparing 6-amino-4-[[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino]-7-ethoxylquinoline 3-carbonitrile." This invention relates to the technical field of pharmaceutical synthesis. The method involves a series of reactions that yield a high-quality product with a short reaction route and simple procedures. The process does not require extreme reaction conditions, which enhances its cost-efficiency and suitability for industrial manufacture.
Career Highlights
Qifa Wang is affiliated with Jiangsu Ocean University, where he continues to engage in research and development in the pharmaceutical field. His innovative approach has led to advancements in the synthesis of important pharmaceutical compounds. His work is recognized for its practical applications and contributions to the industry.
Collaborations
Qifa Wang has collaborated with notable colleagues, including Qingfang Cheng and Chenlin Hua. These collaborations have further enriched his research and development efforts, leading to more innovative solutions in pharmaceutical synthesis.
Conclusion
Qifa Wang is a distinguished inventor whose work in pharmaceutical synthesis has made a significant impact on the industry. His innovative methods and collaborative efforts continue to drive advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile